CALB2 Expression Is Associated with Tumor Progression and Prognosis in Colorectal Adenocarcinoma.
Genes
Yang F, Liu Y, Luo N, Li Q, Hu G.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2026
Cancer Research
No items found.
Key Finding
Globally, colorectal adenocarcinoma (COAD) continues to be one of the most frequent contributors to cancer-associated deaths, pointing out an ongoing demand for robust biomarkers capable of reflecting disease advancement and predicting patient outcomes. Collectively, these findings show a correlation between CALB2 expression and poor clinical outcomes and disease progression in colorectal adenocarcinoma.
Countstar Connection
For the study's cell samples, Countstar (model not specified) provided cell-count measurements during culture monitoring in the 2026 Genes study.
